The United Nations Office on Drugs and Crime reports record growth in the global trade of illicit drugs in its latest annual report [1].
The findings signal a critical escalation in the availability of dangerous substances, highlighting a shift in production and market demand that threatens public health on a global scale.
According to the UNODC, an estimated 331 million people used a drug in 2024 [1]. This figure represents 6.2% of the global population aged 15 to 64 [1]. The report said there was an unprecedented spike in the emergence of new drugs, contributing to the overall growth of the illicit market [1].
Production of cocaine, methamphetamine, and new synthetic opioids has surged [2]. The UNODC said this boom in production is coupled with a rise in seizures, suggesting a high volume of traffic moving through global supply chains [2].
Regional trends show a particular concentration of activity in Southeast Asia, where the illicit methamphetamine trade has reached a record high [4]. The surge is driven by increased production capabilities and shifting market dynamics [3].
Market shifts and rising demand have further fueled the expansion of these trades [3]. The report said the combination of traditional drug growth and the rise of synthetic alternatives is creating a more complex landscape for international law enforcement and health agencies [2].
“331 million people used a drug in 2024”
The record growth in synthetic drug production indicates a decoupling of illicit drug trades from traditional agricultural precursors. As production shifts toward synthetic opioids and methamphetamines, the speed of manufacture increases and the geographic footprint expands, making traditional border interdiction less effective and increasing the risk of widespread overdose crises.
